Ongoing mumps outbreak in Israel, January to August 2017

• Published in: Euro surveillance : bulletin européen sur les maladies transmissibles Vol. 22; no. 35; p. 2
• Main Authors: Indenbaum, Viki, Hübschen, Judith M, Stein-Zamir, Chen, Mendelson, Ella, Sofer, Danit, Hindiyeh, Musa, Anis, Emilia, Abramson, Nitza, Haas, Eric J, Yosef, Yochi, Dukhan, Larisa, Singer, Shepherd Roee
• Format: Journal Article
• Language: English
• Published: Sweden Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) 31.08.2017; European Centre for Disease Prevention and Control (ECDC)
• Subjects: Adolescent; Age Distribution; Disease Outbreaks; Epidemics; Female; Genotype; Genotype & phenotype; Humans; Immunoglobulin M; Israel - epidemiology; Male; Mumps; Mumps - epidemiology; Mumps virus - genetics; Mumps virus - isolation & purification; Polymerase Chain Reaction; Rapid Communication; Sex Distribution; Vaccines; Viral Proteins - genetics; Viral Proteins - isolation & purification; Young Adult; Israel; epidemiology; infection control; Mumps; outbreaks; surveillance; measles-mumps-rubella (MMR) vaccine
• ISSN: 1560-7917; 1025-496X; 1560-7917
• DOI: 10.2807/1560-7917.ES.2017.22.35.30605

In Israel, 262 mumps cases were registered between 1 January and 28 August 2017 despite a vaccine coverage of ≥ 96%. The majority (56.5%) of cases were adolescents and young adults between 10 and 24 years of age. Nearly twice as many cases were reported in males than in females. Sequence information identified genotype G and suggested specific transmission chains in different religious communities, with the Muslim population in Jerusalem being most severely affected.